Power data on the first dose of Pfizer's vaccine:
A single dose of Pfizer’s vaccine helped prevent severe COVID-19 illnesses in volunteers.
thehill.com
Ahead of Pfizer and BioNTech’s COVID-19 vaccine candidate being approved for emergency use by the U.S. Food and Drug Administration (FDA), new documents reveal that the vaccine maintained its high efficacy rate, even with just one dose.
Now, new documents reveal that the vaccine showcases an 88.9 efficacy rate following just one dose. The FDA released the documents ahead of a Dec. 10 meeting between the Center for Biologics Evaluation and Research’s (CBER), Vaccines and the Related Biological Products Advisory Committee (VRBPAC) to discuss emergency use authorization for the vaccine.